Show simple item record

dc.contributor.authorBonet Martínez, Fernando 
dc.contributor.authorInácio, José M.
dc.contributor.authorBover, Oriol
dc.contributor.authorAñez, Sabrina B.
dc.contributor.authorBelo, Jose A.
dc.date.accessioned2022-04-18T10:05:48Z
dc.date.available2022-04-18T10:05:48Z
dc.date.issued2022-02
dc.identifier.issn1664-8021
dc.identifier.urihttp://hdl.handle.net/10498/26560
dc.description.abstractThe collagen- and calcium-binding EGF-like domains 1 (CCBE1) is a secreted protein extensively described as indispensable for lymphangiogenesis during development enhancing VEGF-C signaling. In human patients, mutations in CCBE1 have been found to cause Hennekam syndrome, an inherited disease characterized by malformation of the lymphatic system that presents a wide variety of symptoms such as primary lymphedema, lymphangiectasia, and heart defects. Importantly, over the last decade, an essential role for CCBE1 during heart development is being uncovered. In mice, Ccbe1 expression was initially detected in distinct cardiac progenitors such as first and second heart field, and the proepicardium. More recently, Ccbe1 expression was identified in the epicardium and sinus venosus (SV) myocardium at E11.5-E13.5, the stage when SV endocardium-derived (VEGF-C dependent) coronary vessels start to form. Concordantly, CCBE1 is required for the correct formation of the coronary vessels and the coronary artery stem in the mouse. Additionally, Ccbe1 was found to be enriched in mouse embryonic stem cells (ESC) and revealed as a new essential gene for the differentiation of ESC-derived early cardiac precursor cell lineages. Here, we bring an up-to-date review on the role of CCBE1 in cardiac development, function, and human disease implications. Finally, we envisage the potential of this molecule's functions from a regenerative medicine perspective, particularly novel therapeutic strategies for heart disease.es_ES
dc.description.sponsorshipOB was a pre-doctoral fellow of Fundacao para a Ciencia e Tecnologia (PD/BD/105891/2015). This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT) grants (PTDC/SAU-ENB/121095/2010, HMSP-ICT/0039/2013 and 02/SAICT/2017/029590) to JA Belo and by the Scientific Employment Stimulus to JMI (Norma Transitoria 8189/2018, FCT), and iNOVA4Health - UIDB/Multi/04462/2020 and UIDP/Multi/04462/2020, a program financially supported by Fundacao para a Ciencia e Tecnologia / Ministerio da Educacao e Ciencia, through national funds is acknowledged.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherFRONTIERS MEDIA SAes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceFront. Genet. 13:836694es_ES
dc.subjectcardiogenesises_ES
dc.subjectcvdes_ES
dc.subjectCCBE1es_ES
dc.subjectHennekam syndromees_ES
dc.subjectlymphangiogenesises_ES
dc.subjectproliferationes_ES
dc.subjectcoronary vesselses_ES
dc.titleCCBE1 in Cardiac Development and Diseasees_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3389/fgene.2022.836694


Files in this item

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This work is under a Creative Commons License Atribución 4.0 Internacional